CSIMarket
 


Collegium Pharmaceutical Inc   (COLL)
Other Ticker:  
 
 

COLL's Net Cash Flow Growth by Quarter and Year

Collegium Pharmaceutical Inc 's Net Cash Flow results by quarter and year




COLL Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -19.59 39.56 -6.82 8.69
III Quarter September -25.22 11.40 -9.53 19.75
II Quarter June 12.77 16.02 19.98 -45.18
I Quarter March 95.79 -79.73 8.67 16.18
FY   63.76 -12.75 12.30 -0.56



COLL Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Collegium Pharmaceutical Inc in the fourth quarter 2023 recorded net cash outflow of $ -19.59 millions.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Net Cash Flow growth. While Collegium Pharmaceutical Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 198 in the fourth quarter 2023.




COLL Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - 69.4 %
III Quarter September - - - 43.12 %
II Quarter June -20.29 % -19.82 % - -
I Quarter March - - -46.42 % -41.88 %
FY   - - - -

Financial Statements
Collegium Pharmaceutical Inc 's fourth quarter 2023 Net Cash Flow $ -19.59 millions COLL's Income Statement
Collegium Pharmaceutical Inc 's fourth quarter 2022 Net Cash Flow $ 39.56 millions Quarterly COLL's Income Statement
New: More COLL's historic Net Cash Flow Growth >>


COLL Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 247.02 % - -56 %
III Quarter September - -28.84 % - -
II Quarter June -86.67 % - 130.45 % -
I Quarter March 142.14 % - -0.23 % 215.4 %
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #15
Overall #198

Net Cash Flow Y/Y Growth Statistics
High Average Low
-101.6 % -192.05 % -312.51 %
(Dec 31 2020)   (Sep 30 2022)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #15
Overall #198
Net Cash Flow Y/Y Growth Statistics
High Average Low
-101.6 % -192.05 % -312.51 %
(Dec 31 2020)   (Sep 30 2022)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Collegium Pharmaceutical Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


COLL's IV. Quarter Q/Q Net Cash Flow Comment
Despite the fact, that Collegium Pharmaceutical Inc in the IV. Quarter 2023 revealed net cash outflow of $ -19.59 millions, it should be mentioned, that those numbers show slight up side compare to the -25.22 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Collegium Pharmaceutical Inc achieved highest sequential Net Cash Flow growth. While Collegium Pharmaceutical Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


COLL's IV. Quarter Q/Q Net Cash Flow Comment
Although Collegium Pharmaceutical Inc in the IV. Quarter 2023 revealed net cash outflow of $ -19.59 millions, some analyst said, that this show recovery compare to the -25.22 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Collegium Pharmaceutical Inc achieved highest sequential Net Cash Flow growth. While Collegium Pharmaceutical Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Collegium Pharmaceutical Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 63.76 $ 122.91 $ 159.53 $ 162.78 $ -12.74
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) -48.12 % -22.96 % -2 % - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 198 # 267 # 342 # 0 # 268




Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Collegium Pharmaceutical Inc had cumulative twelve months Net Cash Flow of $ 64 millions compare to net cash outflow of $ -13 millions a year ago.

Collegium Pharmaceutical Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-101.6 %
-192.05 %
-312.51 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 15
S&P 500 # 198
Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Collegium Pharmaceutical Inc had cumulative twelve months Net Cash Flow of $ 64 millions compare to net cash outflow of $ -13 millions a year ago.

Collegium Pharmaceutical Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-101.6 %
-192.05 %
-312.51 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 15
S&P 500 # 198




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
COLL's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for COLL's Competitors
Net Cash Flow Growth for Collegium Pharmaceutical Inc 's Suppliers
Net Cash Flow Growth for COLL's Customers

You may also want to know
COLL's Annual Growth Rates COLL's Profitability Ratios COLL's Asset Turnover Ratio COLL's Dividend Growth
COLL's Roe COLL's Valuation Ratios COLL's Financial Strength Ratios COLL's Dividend Payout Ratio
COLL's Roa COLL's Inventory Turnover Ratio COLL's Growth Rates COLL's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com